BioNTech has appointed Swedish Orphan Biovitrum Chief Executive Officer Guido Oelkers as its next Chief Executive Officer. Oelkers will join BioNTech’s Management Board and assume the position by February 1, 2027, succeeding company co-founder Ugur Sahin. Sahin will assist with the transition and Oelkers’ onboarding.
The appointment comes as Sahin and BioNTech Chief Me...